In a report released today, David Larsen from Leerink Partners maintained a Hold rating on Athenahealth (NASDAQ: ATHN), with a price target of $160. The company’s shares opened today at $157.41, close to its 52-week high of $163.94.
According to TipRanks.com, Larsen is a 2-star analyst with an average return of 1.4% and a 37.0% success rate. Larsen covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Cardinal Health, and Express Scripts.
Currently, the analyst consensus on Athenahealth is Moderate Buy and the average price target is $158, representing a 0.4% upside.
In a report released yesterday, Canaccord Genuity also maintained a Hold rating on the stock with a $125 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $163.94 and a one-year low of $111.61. Currently, Athenahealth has an average volume of 518.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
athenahealth, Inc. engages in the provision of cloud-based business services and mobile applications for medical groups and health systems. It offers network-based medical record, revenue cycle, patient engagement, care coordination, population health services, and other point-of-care mobile applications.
